Appropriateness Criteria and Elective Procedures — Total Joint Arthroplasty
|
Hassan M.K. Ghomrawi, Ph.D., M.P.H., Bruce R. Schackman, Ph.D., and Alvin I. Mushlin, M.D. |
2012 |
N Engl J Med 2012; 367:2467-2469 |
Open
|
Disparities in the Use of Total Joint Arthroplasty
|
Mary E. Charlson, M.D., and John P. Allegrante, Ph.D. |
2000 |
N Engl J Med 2000; 342:1044-1045 |
Open
|
Minimally Invasive Total Knee Arthroplasty
|
|
2009 |
N Engl J Med 2009; 361:633-634 |
Open
|
The Technique of Total Hip Arthroplasty
|
Thomas A. Einhorn, M.D. |
1993 |
N Engl J Med 1993; 328:591-592 |
Open
|
Venous Thromboembolism Prophylaxis after Hip or Knee Arthroplasty
|
|
2018 |
N Engl J Med 2018; 378:1848-1849 |
Open
|
Association of Medicare Mandatory Bundled Payment Reform With Joint Replacement Surgery Use for Beneficiaries With Alzheimer Disease and Related Dementias
|
Caroline P. Thirukumaran, MBBS, MHA, PhD1,2,3; Benjamin F. Ricciardi, MD1,3; Xueya Cai, PhD4; et al |
2022 |
JAMA Health Forum. 2022;3(2):e215111. |
Open
|
Occult Vitamin D Deficiency in Postmenopausal US Women With Acute Hip Fracture
|
Meryl S. LeBoff, MD; Lynn Kohlmeier, MD; Shelley Hurwitz, PhD; et al |
1999 |
JAMA. 1999;281(16):1505-1511. |
Open
|
Preoperative vs Postoperative Initiation of Low-Molecular-Weight Heparin Prophylaxis Against Venous Thromboembolism in Patients Undergoing Elective Hip Replacement
|
Russell D. Hull, MBBS, MSC; Rollin F. Brant, PhD; Graham F. Pineo, MD; et al |
1999 |
Arch Intern Med. 1999;159(2):137-141. |
Open
|
Rehabilitation After Hip and Knee Arthroplasty—Reply
|
Michael C. Munin, MD; Thomas E. Rudy, PhD; Nancy W. Glynn, PhD; et al |
1998 |
JAMA. 1998;280(16):1402-1403. |
Open
|
Rehabilitation After Hip and Knee Arthroplasty
|
Aaron M. Levine, MD |
1998 |
JAMA. 1998;280(16):1402-1403. |
Open
|
Incidence and Time Course of Thromboembolic Outcomes Following Total Hip or Knee Arthroplasty
|
Richard H. White, MD; Patrick S. Romano, MD, MPH; Hong Zhou, PhD; et al |
1998 |
Arch Intern Med. 1998;158(14):1525-1531. |
Open
|
Incidence and Time Course of Thromboembolic Outcomes Following Total Hip or Knee Arthroplasty
|
Richard H. White, MD; Patrick S. Romano, MD, MPH; Hong Zhou, PhD; et al |
1998 |
Arch Intern Med. 1998;158(14):1525-1531. |
Open
|
Incidence and Time Course of Thromboembolic Outcomes Following Total Hip or Knee Arthroplasty
|
Richard H. White, MD; Patrick S. Romano, MD, MPH; Hong Zhou, PhD; et al |
1998 |
Arch Intern Med. 1998;158(14):1525-1531. |
Open
|
Role of Rifampin for Treatment of Orthopedic Implant–Related Staphylococcal Infections
|
Werner Zimmerli, MD; Andreas F. Widmer, MD, MSc; Marianne Blatter, MD; et al |
1998 |
JAMA. 1998;279(19):1537-1541. |
Open
|
The Incidence of Symptomatic Venous Thromboembolism During and After Prophylaxis With Enoxaparin
|
Jacques R. Leclerc, MD; Michael Gent, DSc; Jack Hirsh, MD; et al |
1998 |
Arch Intern Med. 1998;158(8):873-878. |
Open
|
Inpatient Rehabilitation After Total Joint Replacement
|
Joseph D. Zuckerman, MD |
1998 |
JAMA. 1998;279(11):880. |
Open
|
Early Inpatient Rehabilitation After Elective Hip and Knee Arthroplasty
|
Michael C. Munin, MD; Thomas E. Rudy, PhD; Nancy W. Glynn, PhD; et al |
1998 |
JAMA. 1998;279(11):847-852. |
Open
|
Subcutaneous Low-Molecular-Weight Heparin vs Warfarin for Prophylaxis of Deep Vein Thrombosis After Hip or Knee Implantation
|
Russell D. Hull, MBBS, MSc; Gary E. Raskob, MSc; Graham F. Pineo, MD; et al |
1997 |
Arch Intern Med. 1997;157(3):298-303. |
Open
|
Timing of Initial Administration of Low-Molecular-Weight Heparin Prophylaxis Against Deep Vein Thrombosis in Patients Following Elective Hip Arthroplasty
|
Russell D. Hull, MBBS; Graham F. Pineo, MD; Paul D. Stein, MD; et al |
2001 |
Arch Intern Med. 2001;161(16):1952-1960. |
Open
|
Dalteparin vs Warfarin in Hip Arthroplasty Patients
|
Albert E. Bajjoka, PHARMD, BCPS |
2001 |
Arch Intern Med. 2001;161(5):771-778. |
Open
|
Dalteparin vs Warfarin in Hip Arthroplasty Patients—Reply
|
Russell Hull, MBBS, MSC; Graham Pineo, MD; Charles Francis, MD; et al |
2001 |
Arch Intern Med. 2001;161(5):771-778. |
Open
|
Dalteparin vs Warfarin in Hip Arthroplasty Patients—Reply
|
Russell Hull, MBBS, MSC; Graham Pineo, MD; Charles Francis, MD; et al |
2001 |
Arch Intern Med. 2001;161(5):771-778. |
Open
|
The Effect of Age on Pain, Function, and Quality of Life After Total Hip and Knee Arthroplasty
|
C. Allyson Jones, PhD; Donald C. Voaklander, PhD; D. William C. Johnston, MD; et al |
2001 |
Arch Intern Med. 2001;161(3):454-460. |
Open
|
Low-Molecular-Weight Heparin Prophylaxis Using Dalteparin in Close Proximity to Surgery vs Warfarin in Hip Arthroplasty Patients
|
Russell D. Hull, MBBS, MSc; Graham F. Pineo, MD; Charles Francis, MD; et al |
2000 |
Arch Intern Med. 2000;160(14):2199-2207. |
Open
|
Low-Molecular-Weight Heparin Prophylaxis Using Dalteparin Extended Out-of-Hospital vs In-Hospital Warfarin/Out-of-Hospital Placebo in Hip Arthroplasty Patients
|
Russell D. Hull, MBBS, MSc; Graham F. Pineo, MD; Charles Francis, MD; et al |
2000 |
Arch Intern Med. 2000;160(14):2208-2215. |
Open
|